1. Academic Validation
  2. Synthesis of Pyrazole-Based Macrocycles Leads to a Highly Selective Inhibitor for MST3

Synthesis of Pyrazole-Based Macrocycles Leads to a Highly Selective Inhibitor for MST3

  • J Med Chem. 2024 Jan 11;67(1):674-690. doi: 10.1021/acs.jmedchem.3c01980.
Jennifer Alisa Amrhein 1 2 Lena Marie Berger 1 2 Dimitrios-Ilias Balourdas 1 2 Andreas C Joerger 1 2 Amelie Menge 1 2 Andreas Krämer 1 2 3 Julia Marie Frischkorn 1 2 Benedict-Tilman Berger 1 2 Lewis Elson 1 2 Astrid Kaiser 1 Manfred Schubert-Zsilavecz 1 Susanne Müller 1 2 Stefan Knapp 1 2 3 Thomas Hanke 1 2
Affiliations

Affiliations

  • 1 Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany.
  • 2 Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe-University Frankfurt, Max-von-Laue-Str. 15, 60438 Frankfurt am Main, Germany.
  • 3 German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), DTKT Site Frankfurt-Mainz 69120 Heidelberg, Germany.
Abstract

MST1, MST2, MST3, MST4, and YSK1 are conserved members of the mammalian sterile 20-like serine/threonine (MST) family that regulate cellular functions such as proliferation and migration. The MST3 isozyme plays a role in regulating cell growth and Apoptosis, and its dysregulation has been linked to high-grade tumors. To date, there are no isoform-selective inhibitors that could be used for validating the role of MST3 in tumorigenesis. We designed a series of 3-aminopyrazole-based macrocycles based on the structure of a promiscuous inhibitor. By varying the moieties targeting the solvent-exposed region and optimizing the linker, macrocycle JA310 (21c) was synthesized. JA310 exhibited high cellular potency for MST3 (EC50 = 106 nM) and excellent kinome-wide selectivity. The crystal structure of the MST3-JA310 complex provided intriguing insights into the binding mode, which is associated with large-scale structural rearrangements. In summary, JA310 demonstrates the utility of macrocyclization for the design of highly selective inhibitors and presents the first chemical probe for MST3.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-160211
    99.83%, MST3 Inhibitor